Dr. Reid is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3855 HEALTH SCIENCES DR Rm 2238
Moores UCSD Cancer Center
La Jolla, CA 92093Phone+1 858-822-6276Fax+1 858-822-6288
Summary
- Dr. Erin Reid is a hematologist in La Jolla, CA and is affiliated with UC San Diego Health. She received her medical degree from UCSF, training at Stanford, & has been in practice for over 20 years. She is experienced lymphomas with a research focus in HIV/AIDS-related lymphoma and Kaposi sarcoma, and serves in national leadership roles within the AIDS Malignancy Consortium (AMC), NCCN, and ASH.
Education & Training
- Stanford UniversityM.S., Epidemiology/Clinical Research, 2003 - 2006
- University of California (San Diego) Medical CenterFellowship, Hematology and Medical Oncology, 2004 - 2004
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 2001 - 2004
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2000 - 2001
- Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 1999 - 2000
- University of California San Francisco School of MedicineClass of 1999
- Stanford UniversityBS, Biology, Phi Beta Kappa, Honors, 1990 - 1994
Certifications & Licensure
- CA State Medical License 2000 - 2026
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Top Doctors:San Diego Area Castle Connolly, 2013
- Top Doctors:Southern California Castle Connolly, 2012
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Join now to see all
Clinical Trials
- Valproic Acid in Treating Patients With Kaposi's Sarcoma Start of enrollment: 2005 Feb 01
- Imatinib Mesylate in Treating Patients With HIV-Related Kaposi's Sarcoma Start of enrollment: 2005 Jun 01
- Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma Start of enrollment: 2006 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsEvaluating the impact of a year-long external mentorship pilot program in classical hematology.Zoya Qureshy, Pooja Nair, Sara K Vesely, Allison A King, Alfred I Lee
Blood Advances. 2024-09-24 - Current Multidisciplinary Lymphoma and Myeloma Management for Surgeons.William B Pearse, Erin G Reid
Surgical Oncology Clinics of North America. 2024-04-01 - 27 citationsNCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023.Andrew D Zelenetz, Leo I Gordon, Jeremy S Abramson, Ranjana H Advani, Babis Andreadis
Journal of the National Comprehensive Cancer Network. 2023-11-01
Journal Articles
- Venetoclax, Bendamustine, and Rituximab in Patients with Relapsed or Refractory NHL: A Phase 1b Dose-Finding StudyN Fowler, E Reid, L J Nastoupil, Annals of Oncology
Abstracts/Posters
- Preliminary Safety and Anti-Tumor Activity of XmAb13676, an Anti-CD20 x Anti-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Non-HodgkinÍs Lymphoma and C...Erin G. Reid, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Cirmtuzumab, a ROR1 Targeted Mab, Reverses Cancer Stemness, and Its Combination with Ibrutinib Is Safe and Effective: Planned Analysis of the Cirll Phase 1/2 Trial for...Erin G. Reid, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Cirmtuzumab, a ROR1 Targeted Mab, Reverses Cancer Stemness, and Its Combination with Ibrutinib Is Safe and Effective: Planned Analysis of the Cirll Phase 1/2 Trial for...Erin G. Reid, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Press Mentions
- How Much Work Are You Really Supposed to Do at Work?September 27th, 2021
- Expert Q&A: Understanding the Oncogenic Role of HIV in Burkitt LymphomaAugust 27th, 2020
- Three Things Lockdowns Have Exposed About Working and ParentingApril 27th, 2020
- Join now to see all
Committees
- Co-Chair, NCCN Guideline Panel: Cancer in People Living with HIV 2016 - Present
- Co-Chair, NCCN Guideline Panel: AIDS-Related Kaposi Sarcoma 2016 - Present
- Member, NCCN Guideline Panel: B-Cell Lymphomas 2014 - Present
- Scientific Planning Committee, AIDS Malignancy Consortium 2013 - Present
- Vice-Chair, Lymphoma Working Group, AIDS Malignancy Consortium, 2009 - Present
- Steering Committee, AIDS Malignancy Consortium 2009 - Present
- Kaposi Sarcoma Working Group, AIDS Malignancy Consortium 2005 - Present
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: